Yuzhong Duan
Xinqiao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Durvalumab Consolidation Treatment Following Concurrent Chemoradiotherapy in Limited-Stage SCLC: ADRIATIC China Subgroup Analysis.
Journal: JTO clinical and research reports
Published: November 07, 2025
The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations.
Journal: Frontiers in oncology
Published: January 26, 2021
Clinical benefits of Livin peptide-loaded DCs/CIKs combined with chemotherapy in advanced non-small cell lung cancer.
Journal: American journal of cancer research
Published: December 01, 2018
Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations.
Journal: The oncologist
Published: November 18, 2018
Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation.
Journal: Oncotarget
Published: April 11, 2016
Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: January 13, 2016
Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Journal: Radiation oncology (London, England)
Published: December 24, 2015
IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
Journal: Oncology reports
Published: October 03, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026